Evaluation of a Protocol for Reducing Venous Thromboembolism in Hematopoietic Stem Cell Transplant Recipients

J Pharm Pract. 2024 Aug;37(4):807-809. doi: 10.1177/08971900231193531. Epub 2023 Aug 3.

Authors

Rachel Abramova¹, Maxwell Brown², Christan Thomas¹, David Salerno², Amer Assal³, Peter Campbell¹

Affiliations

¹ Department of Pharmacy, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, NY, USA.
² Department of Pharmacy, Weill Cornell Medical Center, NewYork-Presbyterian Hospital, New York, NY, USA.
³ Department of Medicine, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, NY, USA.

PMID: 37534419
DOI: 10.1177/08971900231193531

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Clinical Protocols
Female
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Male
Middle Aged
Venous Thromboembolism* / etiology
Venous Thromboembolism* / prevention & control